172 related articles for article (PubMed ID: 23183178)
1. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
[TBL] [Abstract][Full Text] [Related]
2. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
Hamidi S; Chen CR; McLachlan SM; Rapoport B
Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
[TBL] [Abstract][Full Text] [Related]
4. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
[TBL] [Abstract][Full Text] [Related]
5. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
[TBL] [Abstract][Full Text] [Related]
6. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
7. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies.
Chazenbalk GD; Wang Y; Guo J; Hutchison JS; Segal D; Jaume JC; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 1999 Feb; 84(2):702-10. PubMed ID: 10022441
[TBL] [Abstract][Full Text] [Related]
8. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
9. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
[TBL] [Abstract][Full Text] [Related]
10. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
[TBL] [Abstract][Full Text] [Related]
11. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
[TBL] [Abstract][Full Text] [Related]
12. A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain.
Chen CR; Tanaka K; Chazenbalk GD; McLachlan SM; Rapoport B
J Biol Chem; 2001 May; 276(18):14767-72. PubMed ID: 11278376
[TBL] [Abstract][Full Text] [Related]
13. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
15. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.
Chazenbalk GD; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Apr; 89(4):1788-93. PubMed ID: 15070946
[TBL] [Abstract][Full Text] [Related]
16. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
17. Hormone- and antibody-mediated activation of the thyrotropin receptor.
Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
[TBL] [Abstract][Full Text] [Related]
18. Antibody protection reveals extended epitopes on the human TSH receptor.
Latif R; Teixeira A; Michalek K; Ali MR; Schlesinger M; Baliram R; Morshed SA; Davies TF
PLoS One; 2012; 7(9):e44669. PubMed ID: 22957097
[TBL] [Abstract][Full Text] [Related]
19. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
